seed
Stage
1
Investors
About
LiquidXO develops regenerative medicine treatments by combining exosome technology with intravenous therapy to improve cellular communication and promote wellness.
Explore LiquidXO's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.